Journal for ImmunoTherapy of Cancer (Nov 2020)
272 Use of LioCyx-M, autologous hepatitis B virus (HBV)-Specific T cell receptor (TCR) T-cells, in advanced HBV-related hepatocellular carcinoma (HCC)
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2020)